Equity Research, Broker Reports, and media content on MaxCyte

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about MaxCyte
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on MaxCyte. We currently have 65 research reports from 4 professional analysts.

Open
150p
Range Today
148/157p
52 Week
108/195p
Daily Volume
482.3k
# Shares
51.4m
Daily Liquidity
(0.94%)
Pension Liability
£0m
Enterprise Value
£76.5m
Market Cap
£78.8m
Latest PE (hist)
Div Yield
Date Source Announcement
20Jan20 07:00 RNS Trading Update
19Dec19 07:00 RNS New Executive Vice President and Trial Update
16Dec19 17:25 RNS Director/PCA transaction initial notification
04Dec19 07:00 RNS Agreement with KSQ Therapeutics
21Nov19 07:00 RNS Vor Biopharma Clinical and Commercial License
14Nov19 07:00 RNS-R Presentation at Jefferies Healthcare Conference
07Nov19 07:00 RNS-R MaxCyte to Present at BIO-Europe 2019
  • Frequency of research reports

     

  • Research reports on

    MaxCyte

  • Providers covering

    MaxCyte